Citigroup’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-22,867
| Closed | -$94K | – | 6900 |
|
|
2022
Q1 | $94K | Sell |
22,867
-33,725
| -60% | -$122K | ﹤0.01% | 4449 |
|
|
2021
Q4 | $202K | Sell |
56,592
-7,907
| -12% | -$27.7K | ﹤0.01% | 4354 |
|
|
2021
Q3 | $235K | Buy |
64,499
+47,893
| +288% | +$194K | ﹤0.01% | 4046 |
|
|
2021
Q2 | $72K | Buy |
16,606
+4,085
| +33% | +$16.6K | ﹤0.01% | 4649 |
|
|
2021
Q1 | $51K | Sell |
12,521
-21,149
| -63% | -$91.6K | ﹤0.01% | 4702 |
|
|
2020
Q4 | $134K | Buy |
33,670
+24,131
| +253% | +$78.1K | ﹤0.01% | 5299 |
|
|
2020
Q3 | $26K | Sell |
9,539
-40,132
| -81% | -$111K | ﹤0.01% | 6015 |
|
|
2020
Q2 | $137K | Buy |
49,671
+3,012
| +6% | +$8.4K | ﹤0.01% | 5313 |
|
|
2020
Q1 | $110K | Sell |
46,659
-117,262
| -72% | -$399K | ﹤0.01% | 5270 |
|
|
2019
Q4 | $770K | Buy |
163,921
+143,579
| +706% | +$588K | ﹤0.01% | 4027 |
|
|
2019
Q3 | $68K | Sell |
20,342
-24,819
| -55% | -$81.7K | ﹤0.01% | 5939 |
|
|
2019
Q2 | $149K | Buy |
45,161
+1,840
| +4% | +$5.32K | ﹤0.01% | 5518 |
|
|
2019
Q1 | $132K | Buy |
43,321
+7,854
| +22% | +$25.5K | ﹤0.01% | 5487 |
|
|
2018
Q4 | $96K | Sell |
35,467
-4,228
| -11% | -$13.9K | ﹤0.01% | 5692 |
|
|
2018
Q3 | $134K | Sell |
39,695
-6,042
| -13% | -$18.7K | ﹤0.01% | 5636 |
|
|
2018
Q2 | $119K | Buy |
45,737
+3,194
| +8% | +$7.95K | ﹤0.01% | 5561 |
|
|
2018
Q1 | $94K | Buy |
42,543
+3,096
| +8% | +$6.97K | ﹤0.01% | 5676 |
|
|
2017
Q4 | $78K | Buy |
39,447
+38,995
| +8,627% | +$84.9K | ﹤0.01% | 5853 |
|
|
2017
Q3 | $1K | Sell |
452
-495
| -52% | -$1.53K | ﹤0.01% | 7183 |
|
|
2017
Q2 | $3K | Buy |
+947
| New | +$2.68K | ﹤0.01% | 6926 |
|
|
2016
Q4 | – | Sell |
-6,162
| Closed | -$10K | – | 7382 |
|
|
2016
Q3 | $10K | Sell |
6,162
-2,200
| -26% | -$2.69K | ﹤0.01% | 6551 |
|
|
2016
Q2 | $9K | Sell |
8,362
-129,428
| -94% | -$125K | ﹤0.01% | 6611 |
|
|
2016
Q1 | $120K | Buy |
137,790
+75,259
| +120% | +$72.8K | ﹤0.01% | 5533 |
|
|
2015
Q4 | $75K | Buy |
62,531
+44,460
| +246% | +$61.9K | ﹤0.01% | 5618 |
|
|
2015
Q3 | $31K | Sell |
18,071
-96,002
| -84% | -$188K | ﹤0.01% | 5730 |
|
|
2015
Q2 | $237K | Buy |
114,073
+10,344
| +10% | +$25.1K | ﹤0.01% | 4304 |
|
|
2015
Q1 | $281K | Sell |
103,729
-18,734
| -15% | -$47.5K | ﹤0.01% | 4223 |
|
|
2014
Q4 | $314K | Buy |
122,463
+7,748
| +7% | +$17.4K | ﹤0.01% | 4314 |
|
|
2014
Q3 | $210K | Buy |
114,715
+18,729
| +20% | +$40.8K | ﹤0.01% | 4198 |
|
|
2014
Q2 | $256K | Sell |
95,986
-24,963
| -21% | -$75.1K | ﹤0.01% | 3925 |
|
|
2014
Q1 | $424K | Sell |
120,949
-31,118
| -20% | -$138K | ﹤0.01% | 3624 |
|
|
2013
Q4 | $680K | Buy |
152,067
+53,246
| +54% | +$217K | ﹤0.01% | 3534 |
|
|
2013
Q3 | $402K | Buy |
98,821
+1,414
| +1% | +$6.18K | ﹤0.01% | 3612 |
|
|
2013
Q2 | $406K | Buy |
+97,407
| New | +$376K | ﹤0.01% | 3671 |
|
Other funds holding ATRS
Citigroup's ATRS Position: Q2 2022 in Review
Citigroup sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 22,867 shares — an estimated $94K sold.
Citigroup first reported a position in ATRS in Q2 2013 and held it in 34 quarters. The position peaked at $770K in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Citigroup reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Citigroup sold 22,867 Antares Pharma, Inc. shares in Q2 2022, an estimated $94K.
- Citigroup first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 34 quarters.
- Citigroup's Antares Pharma, Inc. position peaked at $770K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.